Skip to content
Screener

Absci Corporation ABSI Other operating expenses

Other operating expenses at other companies

Schrodinger logo
SchrodingerSDGR
$73.98M-6.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$66.83M+0.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Assembly Biosciences logo
Assembly BiosciencesASMB
$19.58M+1.2%
Xencor logo
XencorXNCR
$88.29M+15.0%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$318.0K-46.4%
Operating income-$34.2M-8.8%
Net income-$33.2M-8.6%
EPS (diluted)-$0.21+12.5%

Balance sheet

See full
Cash & equivalents$108.9M+97.0%
Total debt$3.7M-32.2%
Total equity$246.1M+42.0%
Total assets$268.9M+28.1%

Cash flow

See full
Operating cash flow-$27.6M-63.4%
CapEx$1.0K-99.6%
Free cash flow-$27.6M-61.2%

Valuation

See full
Market cap$1.51B+271%
Enterprise value$1.41B+293%
P/S969.1×+871×

Profitability

See full
Operating margin-8,084.5%-17,708pp
Net margin-7,756.4%-17,069pp
FCF margin-6,981%-10,936pp

Returns & leverage

See full
Return on equity-57.7%+0.3pp
Debt / equity0.0×
Current ratio10.6×+6.2×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Absci Corporation’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 4:08 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001672688-26-000136
(In thousands, except for share and per share data)For the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Research and development22,61620,45841,89136,822
Selling, general and administrative9,1648,52818,22218,000
Depreciation and amortization2,6963,0005,4246,072
Total operating expenses34,47631,98665,53760,894
Operating loss(34,158)(31,393)(65,004)(59,122)
Other income (expense)
Interest expense(2)(56)(20)(135)
Other income, net9901,0112,2732,469

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is Absci Corporation's other operating expenses?
Absci Corporation (ABSI) reported other operating expenses of $34.48M in Q2 2026.
How has Absci Corporation's other operating expenses changed year-over-year?
Absci Corporation's other operating expenses increased by 7.8% year-over-year, from $31.99M to $34.48M.
What is the long-term trend for Absci Corporation's other operating expenses?
Over 4 years (2021 to 2025), Absci Corporation's other operating expenses has grown at a 11.4% compound annual growth rate (CAGR), from $80.02M to $123.12M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Absci Corporation's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude